Mycoplasmas may colonize tumor tissue in patients.
Mycoplasma-encoded cytidine deaminase deaminates cytosine-based anticancer drugs.
The activity of gemcitabine is compromised in mycoplasma-infected tumor cells.
Gemcitabine activity can be restored by nucleosides or a PNP inhibitor.